GLP‐1 receptor agonists for Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"GLP‐1 Receptor Agonists for Parkinson's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436930/all/Safety_of_regular_formoterol_or_salmeterol_in_adults_with_asthma:_an_overview_of_Cochrane_reviews. Accessed 19 April 2024.
GLP‐1 receptor agonists for Parkinson's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436930/all/Safety_of_regular_formoterol_or_salmeterol_in_adults_with_asthma:_an_overview_of_Cochrane_reviews. Accessed April 19, 2024.
GLP‐1 receptor agonists for Parkinson's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/436930/all/Safety_of_regular_formoterol_or_salmeterol_in_adults_with_asthma:_an_overview_of_Cochrane_reviews
GLP‐1 Receptor Agonists for Parkinson's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436930/all/Safety_of_regular_formoterol_or_salmeterol_in_adults_with_asthma:_an_overview_of_Cochrane_reviews.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - GLP‐1 receptor agonists for Parkinson's disease
ID - 436930
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436930/all/Safety_of_regular_formoterol_or_salmeterol_in_adults_with_asthma:_an_overview_of_Cochrane_reviews
DB - Evidence Central
DP - Unbound Medicine
ER -